Table 2.

Headache Relief Rates 2 Hours Postdose and Sumatriptan or Other 5HT1 Agonist Use by Subgroup Factors

PlaceboSumatriptan NS (mg/Dose)
51020
Age, n (%)
 12–14 y41 (55%)56 (72%)59 (69%)44 (63%)
 15–17 y28 (50%)28 (57%)26 (54%)30 (64%)
Sumatriptan/5HT1
agonist use, n (%)
 None41 (55%)53 (67%)54 (68%)42 (65%)
 Any formulation28 (52%)28 (62%)30 (59%)32 (62%)